Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses

被引：0

作者：

Mdluli, Thembi ^{[1
,2
]}

Wollen-Roberts, Suzanne ^{[1
,2
]}

Merbah, Melanie ^{[1
,2
]}

Beckman, Bradley ^{[1
,2
]}

Li, Yifan ^{[1
,2
]}

Alrubayyi, Aljawharah ^{[1
,2
]}

Curtis, Daniel J. ^{[1
,2
]}

Shubin, Zhanna ^{[1
,2
,15
]}

Barrera, Michael D. ^{[1
,2
]}

Boeckelman, Jacob ^{[1
,2
]}

Duncan, Shayla ^{[1
,2
]}

Thapa, Pallavi ^{[1
,2
]}

Kim, Dohoon ^{[1
,2
]}

Costanzo, Margaret C. ^{[1
,2
]}

Bai, Hongjun ^{[1
,2
]}

Dearlove, Bethany L. ^{[1
,2
]}

Hooper, Jay W. ^{[3
]}

Kwilas, Steven A. ^{[3
]}

Paquin-Proulx, Dominic ^{[1
,2
]}

Eller, Michael A. ^{[1
,2
,16
]}

Eller, Leigh Anne ^{[1
,2
]}

Kibuuka, Hannah ^{[4
]}

Mwesigwa, Betty ^{[4
]}

Kosgei, Josphat ^{[5
,6
]}

Sawe, Fredrick ^{[5
,6
]}

Oyieko, Janet ^{[5
,6
]}

Ntinginya, Nyanda ^{[7
]}

Mwakisisile, Joel ^{[7
]}

Jani, Ilesh ^{[8
]}

Viegas, Edna ^{[8
]}

Iroezindu, Michael ^{[1
,9
]}

Akintunde, Akindiran ^{[2
,9
,10
]}

Paolino, Kristopher ^{[11
,12
]}

Robb, Merlin L. ^{[1
,2
]}

Ward, Lucy ^{[13
]}

McLean, Chelsea ^{[14
]}

Luhn, Kerstin ^{[14
]}

Robinson, Cynthia ^{[14
]}

Ake, Julie A. ^{[1
]}

Rolland, Morgane ^{[1
,2
]}

机构：

[1] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA

[2] Henry M Jackson Fdn Advancement Mil Med Inc, Bethesda, MD 20817 USA

[3] US Army Med Res Inst Infect Dis USAMRIID, Ft Detrick, MD 21702 USA

[4] Makerere Univ, Walter Reed Project, Kampala, Uganda

[5] Henry M Jackson Fdn Med Res Int, Nairobi, Kenya

[6] Kenya Govt Med Res Ctr, US Army Med Res Directorate Africa, Kericho, Kenya

[7] Natl Inst Med Res, Mbeya Med Res Ctr, Mbeya, Tanzania

[8] Polana Can Hlth Res & Training Ctr, Maputo, Mozambique

[9] Henry M Jackson Fdn Med Res Int, Abuja, Nigeria

[10] US Army Med Res Directorate Africa, Abuja, Nigeria

[11] Walter Reed Army Inst Res, Clin Trials Ctr, Silver Spring, MD 20910 USA

[12] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA

[13] US Dept Def DOD Joint Program Execut Off Chem, Joint Project Manager Chem, Biol, Ft Detrick, MD 21702 USA

[14] Janssen Vaccines & Prevent, Leiden, Netherlands

[15] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA

[16] Natl Inst Allergy & Infect Dis, Vaccine Res Program, Div AidS, NIH, Bethesda, MD 20892 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2025年 / 17卷 / 792期

关键词：

2-DOSE HETEROLOGOUS AD26.ZEBOV; PROTECTS NONHUMAN-PRIMATES; OPEN-LABEL; MEDIATED PROTECTION; MONOCLONAL-ANTIBODY; VACCINES; IMMUNOGENICITY; CHALLENGE; REGIMEN; SAFETY;

D O I：

10.1126/scitranslmed.adq2496

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The Janssen Ebola virus (EBOV) vaccine consists of the adenovirus type 26 vector encoding the EBOV glycoprotein (GP) (Ad26.ZEBOV) and the modified vaccinia Ankara (MVA) vector encoding GP from EBOV, Sudan virus, and Marburg virus and nucleoprotein from Tai Forest virus (MVA-BN-Filo) administered 8 weeks later. We conducted a systems immunology analysis of antibody-mediated and cellular immune responses induced after two immunizations with either vaccine used first. The response to vaccination was EBOV GP specific and defined by high antibody binding, Fc effector, and neutralizing responses with CD4 T cell responses also contributing. The vaccine-induced antibody profile did not distinguish people living with or without HIV-1. Samples from 48 survivors and 121 contacts from the 2007 Ugandan Bundibugyo virus epidemic also showed minimal cross-reactivity to other filovirus proteins after infection and exposure. The lack of cross-reactivity suggests that different multivalent vaccine candidates are required to provide broad protection across filoviruses.

引用

页数：16

共 49 条

[1] Duration of immune responses after Ebola virus vaccination
Bradfute, Steven B.
LANCET INFECTIOUS DISEASES, 2016, 16 (01) : 2 - 3
[2] Human Ebola virus infection results in substantial immune activation
McElroy, Anita K.
Akondy, Rama S.
Davis, Carl W.
Ellebedy, Ali H.
Mehta, Aneesh K.
Kraft, Colleen S.
Lyon, G. Marshall
Ribner, Bruce S.
Varkey, Jay
Sidney, John
Sette, Alessandro
Campbell, Shelley
Stroeher, Ute
Damon, Inger
Nichol, Stuart T.
Spiropoulou, Christina F.
Ahmed, Rafi
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (15) : 4719 - 4724
[3] Characterization of host immune responses in Ebola virus infections
Wong, Gary
Kobinger, Gary P.
Qiu, Xiangguo
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (06) : 781 - 790
[4] Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Poetsch, Joseph H.
Dahlke, Christine
Zinser, Madeleine E.
Kasonta, Rahel
Lunemann, Sebastian
Rechtien, Anne
Ly, My L.
Stubbe, Hans C.
Kraehling, Verena
Biedenkopf, Nadine
Eickmann, Markus
Fehling, Sarah K.
Olearo, Flaminia
Strecker, Thomas
Sharma, Piyush
Lang, Karl S.
Lohse, Ansgar W.
Schmiedel, Stefan
Becker, Stephan
Siegrist, Claire-Anne
Huttner, Angela
Addo, Marylyn M.
Bejon, Phillip
Njuguna, Patricia
Ndungu, Francis
Kremsner, Peter G.
Brosnahan, Jessica S.
Agnandji, Selidji Todagbe
Krishna, Sanjeev
Kieny, Marie Paule
Modjarrad, Kayvon
Moorthy, Vasee
Fast, Patricia
Savarese, Barbara
Lapujade, Olivier
JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (04) : 556 - 561
[5] A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus
Balelli, Irene
Pasin, Chloe
Prague, Melanie
Crauste, Fabien
Van Effelterre, Thierry
Bockstal, Viki
Solforosi, Laura
Thiebaut, Rodolphe
JOURNAL OF THEORETICAL BIOLOGY, 2020, 495
[6] Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial
Ake, Julie A.
Paolino, Kristopher
Hutter, Jack N.
Cicatelli, Susan Biggs
Eller, Leigh Anne
Eller, Michael A.
Costanzo, Margaret C.
Paquin-Proulx, Dominic
Robb, Merlin L.
Tran, Chi L.
Anova, Lalaine
Jagodzinski, Linda L.
Ward, Lucy A.
Kilgore, Nicole
Rusnak, Janice
Bounds, Callie
Badorrek, Christopher S.
Hooper, Jay W.
Kwilas, Steven A.
Ilsbroux, Ine
Anumendem, Dickson Nkafu
Gaddah, Auguste
Shukarev, Georgi
Bockstal, Viki
Luhn, Kerstin
Douoguih, Macaya
Robinson, Cynthia
VACCINES, 2024, 12 (05)
[7] The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms
O'Donnell, Kyle
Marzi, Andrea
EXPERT REVIEW OF VACCINES, 2020, 19 (03) : 267 - 277
[8] A Bivalent Bacterium-like Particles-Based Vaccine Induced Potent Immune Responses against the Sudan Virus and Ebola Virus in Mice
Xu, Shengnan
Li, Wujian
Jiao, Cuicui
Cao, Zengguo
Wu, Fangfang
Yan, Feihu
Wang, Hualei
Feng, Na
Zhao, Yongkun
Yang, Songtao
Wang, Jianzhong
Xia, Xianzhu
TRANSBOUNDARY AND EMERGING DISEASES, 2023, 2023
[9] T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species
Grifoni, Alba
Voic, Hannah
Dhanda, Sandeep Kumar
Kidd, Conner K.
Brien, James D.
Buus, Soren
Stryhn, Anette
Durbin, Anna P.
Whitehead, Stephen
Diehl, Sean A.
De Silva, Aruna D.
Balmaseda, Angel
Harris, Eva
Weiskopf, Daniela
Sette, Alessandro
JOURNAL OF VIROLOGY, 2020, 94 (10)
[10] Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection
Fan, Yuchen
Stronsky, Sabrina M.
Xu, Yao
Steffens, Jesse T.
van Tongeren, Sean A.
Erwin, Amanda
Cooper, Christopher L.
Moon, James J.
ACS NANO, 2019, 13 (10) : 11087 - 11096

← 1 2 3 4 5 →